Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection

BACKGROUND: Fingolimod, a sphingosine-1-phosphate receptor modulator with well-described immunomodulatory properties involving peripheral immune cell trafficking, was the first oral agent approved for the treatment of relapsing remitting multiple sclerosis. Analogous immunomodulatory treatment optio...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Neuroinflammation
Prif Awduron: Ambrosius, Björn, Pitarokoili, Kalliopi, Schrewe, Lisa, Pedreiturria, Xiomara, Motte, Jeremias, Gold, Ralf
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2017
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406994/
https://ncbi.nlm.nih.gov/pubmed/28446186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-0864-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg